Acino International AG - Company Profile
Powered by 
All the data and insights you need on Acino International AG in one report.
$295
- Save hours of research time and resources with
our up-to-date Acino International AG Strategy Report
- Understand Acino International AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and women’s health, among others. It also offers business-to-business services such as product development and contract manufacturing, among others. The company's drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland, and Ukraine. The company markets products mainly in the Middle East, Africa, Latin America, Europe, and Asia. Acino is headquartered in Zurich, Switzerland.
Headquarters
Switzerland
Address
Thurgauerstrasse 36-38, Zurich, 8050
Website
acino.swiss
Telephone
41 44 5552200
No of Employees
2,793
Industry
Pharmaceuticals and Healthcare
Acino International AG premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Abelcet (Amphotericin B Lipid Complex) | Contract Manufacturing Services |
| Amlocim (Amlodipine Besilate) | Regulatory Services |
| Angiox (Bivalirudin) | Product Registration |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Acquisitions/Mergers/Takeovers | In December, the company completed the acquisition of M8 Pharmaceuticals, a biopharmaceutical company. |
| 2023 | Acquisitions/Mergers/Takeovers | In March, the company acquired Pharmax Pharmaceuticals. |
| 2023 | Contracts/Agreements | In May, the company enters a collaboration with Janssen to strengthen patient access in South Africa. |
Competitor Comparison
| Key Parameters | Acino International AG | Grunenthal GmbH | Siegfried Holding AG | Basilea Pharmaceutica Ltd | Actelion Pharmaceuticals Ltd |
|---|---|---|---|---|---|
| Headquarters | Switzerland | Germany | Switzerland | Switzerland | Switzerland |
| City | Zurich | Aachen | Zofingen | Allschwil | Allschwil |
| State/Province | Zurich | Nordrhein-Westfalen | - | - | Basel-Landschaft |
| No. of Employees | 2,793 | 4,431 | 3,933 | 147 | - |
| Entity Type | Private | Private | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John Beighton | Chairman | Executive Board | 2019 | - |
| Steffen Saltofte | Chief Executive Officer | Senior Management | 2018 | - |
| Max Sorokin | Chief Financial Officer | Senior Management | 2023 | - |
| Christina Peusch | Chief Legal and Compliance Officer | Senior Management | 2015 | - |
| Mario Ricard | Chief Operations Officer | Senior Management | 2017 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer